在以吗啡为基础的静脉注射患者控制的止痛中,用德罗皮多尔进行抗性预防:倾向性得分与队列研究相匹配
Jia Qi Tan1,2, Hsiang-Ling Wu3,4, Yi-Chien Wang1,2
1Department of Anesthesiology, Shuang Ho Hospital, Taipei Medical University, 23561, New Taipei City, Taiwan.
BMC anesthesiology
|October 29, 2023
概括
在静脉注射患者控制止痛药 (IV-PCA) 中添加多佩里多尔有效地减少术后恶心和吐 (PONV),而不会增加镇静剂或阿片类药物的使用. 然而,晚发性PONV可能仍然需要额外的预防措施.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 手术护理 手术护理
背景情况:
- 有限的现实世界的数据存在于静脉注射患者控制的止痛药 (IV-PCA) 中德罗皮多尔的抗疗效.
- 这项研究调查了多佩里多尔在为大手术患者提供基于吗啡的IV-PCA中的益处和副作用.
研究的目的:
- 为了评估添加到IV-PCA时的德罗皮多尔的抗效果.
- 评估德罗佩里多尔对接受IV-PCA的患者镇静水平的影响.
主要方法:
- 对1104名接受了基于吗啡的IV-PCA的大型手术的患者进行了回顾性分析.
- 倾向性得分匹配 (1:1比) 对于在IV-PCA中使用和不使用德罗皮里多尔的患者.
- 多变量条件逻辑回归用于确定结果的调整几率比率 (aORs).
主要成果:
- 德罗佩里多尔显著降低了术后恶心和/或吐 (PONV) 的风险 (aOR:0.49).
- 抗效应在手术后36小时内最为明显.
- 镇静率和术后阿片类药物消费在各组之间是相似的.
结论:
- 在IV-PCA中的德罗佩里多尔有效地减轻PONV,而不会对镇静或阿片类药物摄入产生不良影响.
- 需要进一步的预防策略来管理晚发性PONV.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
305
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
305
Parenteral Anesthetics: Overview
136
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
136
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
217
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
217
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
214
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
214
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
350
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
350
Opioid Analgesics: Synthetic and Semisynthetic Opioids
311
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
311


